EAM
KDNY

EverPoint Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

EverPoint Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,000
Closed -$2.91M – 553
2015
Q3 		$2.91M Buy
+30,000
New +$3.57M 0.08% 292

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

EverPoint Asset Management's KDNY Position: Q4 2015 in Review

EverPoint Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2015, closing a stake of 30,000 shares — an estimated $2.91M sold.

EverPoint Asset Management first reported a position in KDNY in Q3 2015 and held it in 1 quarter. The position peaked at $2.91M in Q3 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2015.

  • EverPoint Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • EverPoint Asset Management sold 30,000 Chinook Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $2.91M.
  • EverPoint Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • EverPoint Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2.91M in Q3 2015.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2015.

Based on EverPoint Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.